Polymorphisms of the 5HT2A and D2 receptor genes and weight change during olanzapine treatment

被引：0
|
作者：
Olajossy-Hilkesberger, L. [1 ]
Godlewska, B. [2 ]
Tylec, A. [3 ]
Olajossy, M. [3 ]
Marmurowska-Michalowska, H. [3 ]
机构：
[1] Med Univ Vienna Austria, Dept Psychiat & Psychotherapy, Div Biol Psychiat, Vienna, Austria
[2] Med Univ Gdansk, Dept Psychiat, Gdansk, Poland
[3] Med Univ Lublin, Dept Psychiat, Lublin, Poland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70656-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S445 / S445
页数：1
相关论文
共 50 条
  • [31] Isoquinolinone derivatives as potent CNS multi-receptor D2/5-HT1A/5HT2A/5-HT6/5-HT7 agents: Synthesis and pharmacological evaluation
    Jin, Jian
    Zhang, Kunxiao
    Dou, Fei
    Hao, Chao
    Zhang, Yifang
    Cao, Xudong
    Gao, Lanchang
    Xiong, Jiaying
    Liu, Xin
    Liu, Bi-Feng
    Zhang, Guisen
    Chen, Yin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
  • [32] MEDI 493-Aryl amide motif with potent D2/5HT2A antagonist activity
    Graham, James M.
    Bridgett, Barr
    Cho, Stephen
    Linda, Coughenour
    Crawford, Terry
    Gregory, Tracy F.
    Nikam, Sham S.
    Rock, David
    Singer, Jamie
    Walters, Michael A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [33] Association of the 5HT2A and 5HT2C promoter polymorphisms with body mass index (BMI)
    Roberts, JE
    Wacker, MJ
    Tehel, MM
    Rosso, F
    McEchron, CA
    Donnelly, JE
    Godard, MP
    FASEB JOURNAL, 2005, 19 (05): : A1132 - A1132
  • [34] Serotonin 5HT2a receptor variation and episodic memory
    不详
    NEUROSCIENTIST, 2004, 10 (05): : 401 - 401
  • [35] Investigation of Novel Inhibitor for the Serotonin 5HT2A Receptor
    Alshbool, Fatima Z.
    Karim, Zubair A.
    Khasawneh, Fadi T.
    FASEB JOURNAL, 2019, 33
  • [36] ANALYSIS OF POLYMORPHISMS AT THE 5-HT2A AN 5-HT2C RECEPTOR GENES AND RESPONSE TO CLOZAPINE
    ARRANZ, MJ
    SODHI, M
    BALL, D
    SHAM, P
    CURTIS, D
    PRICE, J
    ROBERTS, G
    COLLIER, D
    KERWIN, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1062 - 1062
  • [37] Pharmacogenomic study of risperidone in schizophrenia: Polymorphism of dopamine D2, D3, and serotonin 5HT2A receptors
    Rybakowski, JK
    Leszczynska-Rodziewicz, A
    Czerski, PM
    Borkowska, A
    Dmitrzak, M
    Hauser, J
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 869 - 869
  • [38] [11C]Olanzapine, radiosynthesis and lipophilicity of a new potential PET 5-HT2 and D2 receptor radioligand
    Gao, Mingzhang
    Shi, Zenas
    Wang, Min
    Zheng, Qi-Huang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (07) : 1953 - 1956
  • [39] Polymorphisms of the 5-HT2A Receptor Gene and Clinical Response to Olanzapine in Paranoid Schizophrenia
    Olajossy-Hilkesberger, Luiza
    Godlewska, Beata
    Schosser-Haupt, Alexandra
    Olajossy, Marcin
    Wojcierowski, Jacek
    Landowski, Jerzy
    Marmurowska-Michalowska, Halina
    Kasper, Siegfried
    NEUROPSYCHOBIOLOGY, 2011, 64 (04) : 202 - 210
  • [40] Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics
    Blasi, Giuseppe
    Selvaggi, Pierluigi
    Fazio, Leonardo
    Antonucci, Linda Antonella
    Taurisano, Paolo
    Masellis, Rita
    Romano, Raffaella
    Mancini, Marina
    Zhang, Fengyu
    Caforio, Grazia
    Popolizio, Teresa
    Apud, Jose
    Weinberger, Daniel R.
    Bertolino, Alessandro
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (07) : 1600 - 1608
12345